Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary Active Not Recruiting Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0037144 (Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00588770Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTreatment